# MedHELM boundary note v0.1

Date: 2026 06 16

Status: public preview.

This note explains how the local synthetic Medical AI Failure Atlas surfaces can be mapped toward MedHELM style workflow discussion.

It does not claim MedHELM compatibility, benchmark equivalence, endorsement, clinical validation, clinical deployment readiness, model safety, model ranking, or official acceptance.

## Source anchors checked

Checked on 2026 06 16:

1. MedHELM official site: https://medhelm.org/
2. MedHELM GitHub: https://github.com/PacificAI/medhelm

Current source summary:

1. MedHELM is an open community led benchmark for evaluating language models on medical tasks.
2. The official site describes 121 clinical tasks, 22 subcategories, 31 datasets, and 5 categories.
3. The official site describes measurement across accuracy, calibration, robustness, and writing style.
4. The GitHub repository describes a multi institutional effort focused on clinically grounded benchmarks for health care language models.

## Local mapping boundary

The local repository can discuss mapping toward MedHELM style clinical workflow categories.

Allowed wording:

`MedHELM oriented boundary note`

`mapping toward MedHELM style workflow categories`

`synthetic failure mechanism layer for discussion`

Not allowed wording:

`MedHELM compatible`

`MedHELM validated`

`MedHELM accepted`

`same status as a MedHELM benchmark`

## Local assets

Current public local assets:

1. `data/failure_atlas_external_sample_v0_1.jsonl`
2. `data/medhelm_remote_rescue_metric_v0_1.json`
3. `docs/MEDHELM_REMOTE_RESCUE_BOUNDARY_METRIC_PACKAGE_DRAFT.md`
4. `failure_atlas/public/INDEX.md`
5. `failure_atlas/public/METHODOLOGY.md`

These assets are synthetic and are not a MedHELM submission, accepted scenario, official extension, clinical validation, or model performance report.

## Workflow category mapping

### Clinical decision support

Strongest local mapping:

1. Remote rescue protocol boundary.
2. Missing variable awareness.
3. Urgent escalation without individualized treatment detail.
4. Avoiding unsafe precision under incomplete clinical context.

### Patient communication and education

Strong local mapping:

1. Patient facing medication safety wording.
2. Safety netting without home protocol detail.
3. Clear escalation language.
4. Avoiding copyable treatment instructions.

### Medical research assistance

Secondary mapping:

1. Source support discipline.
2. Evidence reliability.
3. Overconfident source language detection.
4. SourceCheckup routing.

### Administration and workflow

Secondary mapping:

1. Local pathway awareness.
2. Avoiding universal statements about local protocol.
3. Distinguishing triage from institution specific workflow.

### Clinical note generation

Later mapping:

1. Discharge instruction safety wording.
2. Safety netting language.
3. Follow up and escalation wording.

## Metric boundary

The local metric draft is:

`remote_rescue_protocol_boundary_v0_1`

It asks whether a model recognizes urgent danger while avoiding individualized rescue, reversal, insulin, IV drug, or emergency protocol instructions when key clinical variables or local workflow context are missing.

This is only a local metric discussion candidate. It is not an accepted MedHELM metric and not a claim that any model passed or failed MedHELM.

## Track A value

For Türkiye health AI safety infrastructure, this boundary note helps explain how Turkish medical language model safety work can use international workflow categories while keeping local governance claims separate.

It does not claim official Turkish national program status, sandbox access, regulatory approval, or institutional backing.

## Track B value

For global open source medical AI evaluation, this boundary note makes the Failure Atlas contribution legible to benchmark maintainers without claiming compatibility.

## Next safe public action

The next safe action is a separate public issue or discussion only after exact text review and owner clearance.

Any external MedHELM issue must say:

1. Synthetic examples only.
2. No patient data.
3. No model ranking.
4. No clinical validation.
5. No compatibility claim.
